Althoff, RR; Singh, MK; Stringaris, A; Constantino, JN; Amaya-Jackson, L; Benton, TD; Bellonci, C; Bostic, JQ; Chua, JD; Findling, RL; McClellan, JM; Sorter, MT; Waxmonsky, JG; Carlson, GA. Research Agenda in Childhood Impairing Emotional Outbursts: A Report of the AACAP Presidential Taskforce on Emotional Dysregulation. 2024.

Ammerman, RT; Erickson, CA. Innovative Approaches to Addressing Pediatric Mental Health. Pediatric Clinics of North America. 2024; 71:xvii-xix.

Berry-Kravis, E; Abbeduto, L; Hagerman, R; Coffey, CS; Cudkowicz, M; Erickson, CA; McDuffie, A; Hessl, D; Ethridge, L; Tassone, F; Ecklund, D; Costigan, M; Huff, T; Pearson, B. Effects of AFQ056 on language learning in fragile X syndrome. The Journal of Clinical Investigation. 2024; 134:e171723.

Combs, J; Lin, P; DelBello, MP; Carle, AC; Bridge, JA; Axelson, DA; Fornari, V; Feuer, V; Emslie, GJ; Kennard, BD; Porter, SC; Sorter, MT; Barzman, D. Examining Alternative Treatment Settings for Adolescents With Suicidal Thoughts During the COVID-19 Pandemic. 2024.

Eisenberg, DM; Cole, A; Maile, EJ; Salt, M; Armstrong, E; Broad Leib, E; Findley, T; Massa, J; Albin, J; Alston, M; Studer, K; Thomas, O; Trilk, J; Edgar, L. Proposed Nutrition Competencies for Medical Students and Physician Trainees: A Consensus Statement. JAMA network open. 2024; 7:e2435425.

Elmaghraby, R; Pines, A; Geske, JR; Coombes, BJ; Leung, JG; Croarkin, PE; Markota, M; Bobo, WV. Risk of Newly Diagnosed Psychotic Symptoms in Youth Receiving Medications for Attention-Deficit/Hyperactivity Disorder. 2024; 2:135-144.

ElSayed, Z; Suer, N; Westerkamp, G; Liu, JY; Miyakoshi, M; Erickson, C; Pedapati, E. CNN Brain Label-Maker: Computer Vision Based ICA Rejection EEG based System Architecture. Editor, Chun SA; Talbert DA. 2024; 37.

Erickson, CA; Perez-Cano, L; Pedapati, EV; Painbeni, E; Bonfils, G; Schmitt, LM; Sachs, H; Nelson, M; De Stefano, L; Westerkamp, G; Issachar, G; Blaettler, T; Hyvelin, JM; Durham, LA. Safety, Tolerability, and EEG-Based Target Engagement of STP1 (PDE3,4 Inhibitor and NKCC1 Antagonist) in a Randomized Clinical Trial in a Subgroup of Patients with ASD. Biomedicines. 2024; 12:1430.

Ethridge, LE; Pedapati, EV; Schmitt, LM; Norris, JE; Auger, E; De Stefano, LA; Sweeney, JA; Erickson, CA. Validating brain activity measures as reliable indicators of individual diagnostic group and genetically mediated sub-group membership Fragile X Syndrome. Scientific Reports. 2024; 14:22982.

Goin-Kochel, RP; Lozano, I; Duhon, G; Marzano, G; Daniels, A; Law, JK; Diehl, K; Snyder, LA G; Feliciano, P; Chung, WK. Evidence-based recruitment strategies for clinical research: Study personnel's and research participants' perceptions about successful methods of outreach for a U.S. Autism-Research Cohort. Journal of Clinical and Translational Science. 2024; 8:e65.

Iidaka, T; Maesawa, S; Kanayama, N; Miyakoshi, M; Ishizaki, T; Saito, R. Hemodynamic and electrophysiological responses of the human amygdala during face imitation-a study using functional MRI and intracranial EEG. Cerebral Cortex. 2024; 34:bhad488.

Kanbar, L; Osborn, AK; Cifuentes, A; Combs, J; Sorter, MT; Dexheimer, JW; Barzman, DH. 3.4 What Matters Most: A Machine Learning Approach to Identify the Most Important Questions in the Automated Risk Assessment of School Violence. Journal of the American Academy of Child and Adolescent Psychiatry. 2024; 63:s206-s207.

Kanbar, LJ; Mishra, A; Osborn, A; Cifuentes, A; Combs, J; Sorter, M; Barzman, D; Dexheimer, JW. Investigation of bias in the automated assessment of school violence. Journal of Biomedical Informatics. 2024; 157:104709.

Kanu, AA; Johnston, MM; Poweleit, EA; Vaughn, SE; Strawn, JR; Ramsey, LB. Influence of CYP2D6 Metabolizer Status on Risperidone and Paliperidone Tolerability in Children and Adolescents. Journal of Child and Adolescent Psychopharmacology. 2024; 34:34-41.

Kaufmann, WE; Raspa, M; Bann, CM; Gable, JM; Harris, HK; Budimirovic, DB; Lozano, R; Berry-Kravis, E; Velinov, M; Talboy, AL; Uy, RS; Buchanan, C; Frazier, JA; Morris, SM. Latent Class Analysis Identifies Distinctive Behavioral Subtypes in Children with Fragile X Syndrome. Journal of Autism and Developmental Disorders. 2024; 54:725-737.

Klaiman, C; White, S; Richardson, S; McQueen, E; Walum, H; Aoki, C; Smith, C; Minjarez, M; Bernier, R; Pedapati, E; Deng, Y; Jones, W; Gillespie, S; Klin, A. Expert Clinician Certainty in Diagnosing Autism Spectrum Disorder in 16-30-Month-Olds: A Multi-site Trial Secondary Analysis. Journal of Autism and Developmental Disorders. 2024; 54:393-408.

Klein, CC; Modi, AC; Welge, JA; Fornari, VM; Kurtz, B; Blom, TJ; Higdon, C; Correll, CU; DelBello, MP. Adherence Rates and Barriers to Second-Generation Antipsychotic Medication Use in Youth with Bipolar Spectrum Disorders Who Have Overweight/Obesity. Journal of Child and Adolescent Psychopharmacology. 2024; 34:353-358.

Leffler, JM; Romanowicz, M; Brennan, E; Elmaghraby, R; Caflisch, S; Lange, H; Kirtley, AT. Integrated Case Presentation Seminar: Bridging Parallel Fields to Improve Psychiatry and Psychology Learner Experience. Child Psychiatry and Human Development. 2024; 55:1554-1563.

Mendez, EM; Mills, JA; Suresh, V; Stimpfl, JN; Strawn, JR. Trajectory and magnitude of response in adults with anxiety disorders: a Bayesian hierarchical modeling meta-analysis of selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and benzodiazepines. CNS Spectrums. 2024; 29:187-196.

Miyakoshi, M; Kim, H; Nakanishi, M; Palmer, J; Kanayama, N. One out of ten independent components shows flipped polarity with poorer data quality: EEG database study. Human Brain Mapping. 2024; 45:e26540.

Panchavati, S; Daida, A; Edmonds, B; Miyakoshi, M; Oana, S; Ahn, SS; Arnold, C; Salamon, N; Sankar, R; Fallah, A; Speier, W; Nariai, H. Uncovering spatiotemporal dynamics of the corticothalamic network at ictal onset. Epilepsia. 2024; 65:1989-2003.

Poweleit, EA; Vaughn, SE; Desta, Z; Dexheimer, JW; Strawn, JR; Ramsey, LB. Machine Learning-Based Prediction of Escitalopram and Sertraline Side Effects With Pharmacokinetic Data in Children and Adolescents. Clinical Pharmacology and Therapeutics. 2024; 115:860-870.

Protic, D; Breeze, E; Mendoza, G; Zafarullah, M; Abbeduto, L; Hagerman, R; Coffey, C; Cudkowicz, M; Durbin-Johnson, B; Ashwood, P; Talboy, A; Tartaglia, N; Veenstra-VanderWeele, J; Tassone, F. Negative effect of treatment with mGluR5 negative allosteric modulator AFQ056 on blood biomarkers in young individuals with Fragile X syndrome. SAGE Open Medicine. 2024; 12:20503121241282401.

Sadhwani, A; Powers, S; Wheeler, A; Miller, H; Potter, SN; Peters, SU; Bacino, CA; Skinner, SA; Wink, LK; Erickson, CA; Bird, LM; Tan, WH. Developmental milestones and daily living skills in individuals with Angelman syndrome. Journal of Neurodevelopmental Disorders. 2024; 16:32.

Schmitt, LM; Nelson, M; Shaffer, RC; Erickson, CA. A near normal distribution of IQ in Fragile X Syndrome. Scientific Reports. 2024; 14:23058.

Shillington, A; White, L; Doberstein, R; Hopkin, R; Harris, K; Zappia, K; Lamy, M. P351: Genetic testing for patients with neurodevelopmental disorders in the inpatient psychiatry setting may reduce hospital stays and improve behavioral outcomes. 2024; 2:101245.

Sorter, M; Stark, LJ; Glauser, T; McClure, J; Pestian, J; Junger, K; Cheng, TL. Addressing the Pediatric Mental Health Crisis: Moving from a Reactive to a Proactive System of Care. The Journal of Pediatrics. 2024; 265:113479.

Strawn, JR; Poweleit, EA; Taylor, ZL; Mizuno, T; Vaughn, S; Desta, Z; Stancil, S; Ramsey, LB. 84 Using Opportunistic Sampling and Remnant Blood Samples to Develop Pediatric Pharmacokinetic Models to Inform Antidepressant Dosing. Journal of Clinical and Translational Science. 2024; 8:22-23.

Swerdlow, NR; Gonzalez, CE; Raza, MU; Gautam, D; Miyakoshi, M; Clayson, PE; Joshi, YB; Molina, JL; Talledo, J; Thomas, ML; Light, GA; Sivarao, DV. Effects of Memantine on the Auditory Steady-State and Harmonic Responses to 40 Hz Stimulation Across Species. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. 2024; 9:346-355.

Tachibana, K; Miyakoshi, M. Toward a More Meaningful Use of EEG in Moral Neuroscience. American Journal of Bioethics Neuroscience. 2024; 15:209-211.

Takarae, Y; Zanesco, A; Erickson, CA; Pedapati, EV. EEG Microstates as Markers for Cognitive Impairments in Fragile X Syndrome. Brain Topography: journal of functional neurophysiology. 2024; 37:432-446.

Taylor, BJ; Pedersen, KA; Mazefsky, CA; Lamy, MA; Reynolds, CF; Strathmann, WR; Siegel, M. From Alert Child to Sleepy Adolescent: Age Trends in Chronotype, Social Jetlag, and Sleep Problems in Youth with Autism. Journal of Autism and Developmental Disorders. 2024; 54:4529-4539.

Tseng, YL; Su, YK; Chou, WJ; Miyakoshi, M; Tsai, CS; Li, CJ; Lee, SY; Wang, LJ. Neural Network Dynamics and Brain Oscillations Underlying Aberrant Inhibitory Control in Internet Addiction. IEEE transactions on neural systems and rehabilitation engineering. 2024; 32:946-955.

Unaka, N; Kahn, RS; Spitznagel, T; Henize, AW; Carlson, D; Michael, J; Quinonez, E; Anderson, J; Beck, AF; Alexander, CE; Lamy, M; Power-Hays, A; Quinn, CT; Niss, OY. An Institutional Approach to Equity and Improvement in Child Health Outcomes. Pediatrics. 2024; 154:e2023064994.

Whitehead, MR; Ryan, P; Young, MA; Austin, JE; Kramer, K; Harris, E; McClure, JM. Increasing pediatric primary care providers’ confidence and use of in-office interventions for anxiety: an application of the project ECHO model. The Journal of Mental Health Training, Education and Practice. 2024; 19:239-253.

Wright, JR; Astrovskaya, I; Barns, SD; Goler, A; Zhou, X; Shu, C; Snyder, LA G; Han, B; Aarrestad, A; Abbeduto, L; Choi, YB; Clark, N; Clark, R; Coffman, M. Return of genetic research results in 21,532 individuals with autism. Genetics in Medicine. 2024; 26:101202.

Zappia, KJ; Harris, K; Thomas, AJ; Lamy, M. 2.24 Orexin Receptor Antagonists for Treatment of Insomnia Associated With Neurodevelopmental Disorders. Journal of the American Academy of Child and Adolescent Psychiatry. 2024; 63:s191.

Zappia, KJ; Shillington, A; Fosdick, C; Erickson, CA; Lamy, M; Dominick, KC. Neurodevelopmental Disorders Including Autism Spectrum Disorder and Intellectual Disability as a Risk Factor for Delayed Diagnosis of Catatonia. Journal of Developmental and Behavioral Pediatrics. 2024; 45:e137-e142.